1. Efficacy and safety of tofacitinib in Japanese patients with rheumatoid arthritis by background methotrexate dose: A post hoc analysis of clinical trial data. Issue 5 (3rd September 2019) Authors: Takeuchi, Tsutomu; Yamanaka, Hisashi; Yamaoka, Kunihiro; Arai, Shoko; Toyoizumi, Shigeyuki; DeMasi, Ryan; Fukuma, Yuri; Hirose, Tomohiro; Sugiyama, Naonobu; Zwillich, Samuel H.; Tanaka, Yoshiya Journal: Modern rheumatology Issue: Volume 29:Issue 5(2019) Page Start: 756 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. RETRACTED ARTICLE: Safety and effectiveness of high-dose methotrexate (over 8 mg/week) in 2838 Japanese patients with rheumatoid arthritis: A postmarketing surveillance report. Issue 1 (2nd January 2020) Authors: Suzuki, Yasuo; Sugiyama, Naonobu; Fukuma, Yuri; Sugiyama, Noriko; Kokubo, Takeshi Journal: Modern rheumatology Issue: Volume 30:Issue 1(2020) Page Start: (vii) Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Safety and effectiveness of high-dose methotrexate (over 8 mg/week) in 2838 Japanese patients with rheumatoid arthritis: a postmarketing surveillance report. Issue 1 (2nd January 2020) Authors: Suzuki, Yasuo; Sugiyama, Naonobu; Fukuma, Yuri; Sugiyama, Noriko; Kokubo, Takeshi Journal: Modern rheumatology Issue: Volume 30:Issue 1(2020) Page Start: 24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Three-year safety and two-year effectiveness of etanercept in patients with rheumatoid arthritis in Japan: Results of long-term postmarketing surveillance. Issue 5 (3rd September 2019) Authors: Yamanaka, Hisashi; Hirose, Tomohiro; Endo, Yutaka; Sugiyama, Noriko; Fukuma, Yuri; Morishima, Yosuke; Sugiyama, Naonobu; Yoshii, Noritoshi; Miyasaka, Nobuyuki; Koike, Takao Journal: Modern rheumatology Issue: Volume 29:Issue 5(2019) Page Start: 737 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗